Eli Lilly (LLY) EVP Carole Ho discloses 2,741.306 RSUs vesting through 2028

Rhea-AI Filing Summary

Eli Lilly and Company executive Carole Ho, EVP & President of Lilly Neuroscience, reported her beneficial ownership of derivative equity awards. She holds restricted stock units covering 2,741.306 shares of Eli Lilly common stock. These RSUs vest in three installments: 904.631 units on December 1, 2026, 932.044 units on December 1, 2027, and 904.631 units on December 1, 2028. Each restricted stock unit represents a contingent right to receive one share of Eli Lilly common stock, aligning a portion of her compensation with the company’s share performance over time.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Ho Carole

(Last) (First) (Middle)

LILLY CORPORATE CENTER

(Street)

INDIANAPOLIS IN 46285

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/31/2025

3. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Pres, Lilly Neuroscience

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	(1)	Common Stock	2,741.306	(2)	D

Explanation of Responses:

1. The restricted stock units vest in three installments, 904.631 on December 1, 2026, 932.044 on December 1, 2027, and 904.631 on December 1, 2028.

2. Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Jonathan Groff for Carole Ho, pursuant to authorization attached	01/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider ownership did Eli Lilly (LLY) report for Carole Ho?

The filing shows that Carole Ho, EVP & President of Lilly Neuroscience, beneficially owns restricted stock units covering 2,741.306 shares of Eli Lilly common stock.

How many Eli Lilly (LLY) RSUs does Carole Ho have and how do they vest?

Carole Ho has 2,741.306 restricted stock units, vesting in three tranches: 904.631 units on December 1, 2026, 932.044 units on December 1, 2027, and 904.631 units on December 1, 2028.

What does each restricted stock unit represent for Eli Lilly (LLY) executives?

Each restricted stock unit reported in the filing represents a contingent right to receive one share of Eli Lilly and Company common stock.

What is Carole Ho’s role at Eli Lilly (LLY) in this insider report?

In the insider ownership report, Carole Ho is identified as an officer of Eli Lilly & Co, serving as EVP & President, Lilly Neuroscience.

What is the event date for Carole Ho’s Eli Lilly (LLY) insider ownership statement?

The date of the event requiring the insider ownership statement is listed as December 31, 2025.

Does this Eli Lilly (LLY) insider filing include non-derivative common stock holdings?

The excerpted report provides a table for non-derivative securities but only includes detailed information for derivative securities in the form of restricted stock units.